v3.26.1
Shareholders' Equity and Share-based Compensation (Tables)
 9 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Restricted Stock Units Activity
Time-based Restricted Stock Units (“TRSUs”)

The following table summarizes the Company’s TRSU activities for the nine months ended March 31, 2026:
 
Number of Time-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share		Weighted Average
Remaining
Contractual
Term (Years)		Aggregate Intrinsic Value
Nonvested at June 30, 20251,491,926 $28.50 1.66$38,282,821 
Granted756,381 $22.42 
Vested(533,089)$30.63 
Forfeited(94,803)$29.27 
Nonvested at March 31, 20261,620,415 $24.91 1.85$35,908,396 
The following table summarizes the Company’s MSUs activities for the nine months ended March 31, 2026:

 
Number of Market-based Restricted Stock
Units
Weighted Average
Grant Date Fair
Value Per Share		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate Intrinsic Value
Nonvested at June 30, 20251,436,000 $32.32 2.89$36,847,760 
Vested(267,500)$5.17 
Forfeited(74,000)$48.44 
Nonvested at March 31, 20261,094,500 $37.86 2.64$24,254,120 
The following table summarizes the Company’s PRSUs activities for the nine months ended March 31, 2026:

 Number of Performance-based Restricted Stock
Units		Weighted Average
Grant Date Fair
Value Per Share		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate Intrinsic Value
Nonvested at June 30, 2025409,563 $27.71 1.85$10,509,387 
Granted204,000 $21.43 
Vested(138,808)$30.75 
Forfeited(11,817)$46.07 
Nonvested at March 31, 2026462,938 $23.56 2.07$10,258,706 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The assumptions used to estimate the fair values of common shares issued under the ESPP were as follows:
Nine Months Ended March 31,
2026
Volatility rate76.0%
Risk-free interest rate3.7%
Expected term1.3 years
Dividend yield—%
Share-based Compensation, Allocation of Recognized Period Costs
Share-based Compensation Expense
The total share-based compensation expense recognized in the Condensed Consolidated Statements of Loss for the periods presented was as follows:
Three Months Ended March 31,Nine Months Ended March 31,
2026202520262025
(in thousands)(in thousands)
Cost of goods sold$1,071 $1,047 $3,368 $3,185 
Research and development1,231 1,890 5,378 6,018 
Selling, general and administrative2,799 4,199 11,760 12,785 
$5,101 $7,136 $20,506 $21,988